Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TRAF6-deficient mice display hypohidrotic ectodermal dysplasia.

Asuka Naito1, Hisahiro Yoshida, Eri Nishioka

  • 1Division of Oncology, Department of Cancer Biology, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan.

Proceedings of the National Academy of Sciences of the United States of America
|June 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer.

Cell reports·2026
Same author

The Nuclear Export Signal of IκBα Drives RelB Oscillations in the Noncanonical NF-κB Pathway.

Genes to cells : devoted to molecular & cellular mechanisms·2026
Same author

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same author

Real-time search-assisted multiplexed quantitative proteomics reveals system-wide cryptic translation initiation in human cancer cells.

Genome biology·2026
Same author

Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant.

iScience·2025
Same author

A chimeric RNA consisting of siRNA and aptamer for inhibiting dengue virus replication.

NAR molecular medicine·2025

Tumor necrosis factor receptor-associated factor 6 (TRAF6) is crucial for developing skin structures like hair follicles and glands. TRAF6 deficiency causes defects in these epidermal appendages, similar to human ectodermal dysplasia.

Area of Science:

  • Developmental biology
  • Molecular biology
  • Immunology

Background:

  • Tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6) is a key adapter protein mediating signals from TNFR and Toll/IL-1 receptor families.
  • TRAF6 is known to be essential for bone formation and immune/inflammatory system development.
  • Previous studies highlighted TRAF6's role in various biological processes, but its specific function in epidermal development was less understood.

Purpose of the Study:

  • To investigate the role of TRAF6 in the development of epidermal appendages.
  • To identify the specific epidermal structures affected by TRAF6 deficiency.
  • To elucidate the molecular mechanisms by which TRAF6 influences epidermal development, particularly its interaction with relevant receptors.

Main Methods:

Related Experiment Videos

  • Analysis of TRAF6-deficient mice to observe developmental phenotypes.
  • Histological examination of skin tissues from TRAF6-deficient embryos.
  • Investigation of protein-protein interactions between TRAF6 and members of the TNFR superfamily, including XEDAR and TROY/TAJ.
  • Assessment of NF-kappaB activation pathways in relation to TRAF6 and receptor signaling.

Main Results:

  • TRAF6 deficiency leads to defective development of epidermal appendages, including hair follicles, sweat glands, and various sebaceous glands.
  • These defects mirror phenotypes observed in mouse models of hypohidrotic ectodermal dysplasia.
  • Key developmental markers like beta-catenin and mucosal addressin cell adhesion molecule-1 were absent in TRAF6-deficient embryos.
  • TRAF6 was found to associate with XEDAR and TROY/TAJ, but not EDAR.
  • TRAF6 is essential for XEDAR-mediated NF-kappaB activation.

Conclusions:

  • TRAF6 plays an indispensable role in the development of epidermal appendages.
  • TRAF6 signaling, potentially through XEDAR or TROY/TAJ, is critical for epidermal development.
  • The findings suggest TRAF6's involvement in pathways relevant to ectodermal dysplasia.